Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2026-01-10 @ 5:02 PM
Study NCT ID:
NCT00601159
Status:
COMPLETED
Last Update Posted:
2011-07-04
First Post:
2007-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
Sponsor:
Fudan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
200709GP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Base for drug clinical trials, Fudan University cancer hospital
Old Organization:
Fudan University cancer hospital